GlassScriptPhysician profile
Beverly Wood
NPI 1598951527
$1,338.41
in general payments reported to CMS, 2019-2025
11 companies · $196 in 2025
The $196 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $120 · 2022: $230 · 2023: $351 · 2024: $441 · 2025: $196.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $988.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $988.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $413.02 | 2021-2025 | Mitraclip, Ensite, Triclip |
| Cardiva Medical, INC. | $212.59 | 2024-2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Edwards Lifesciences Corporation | $209.80 | 2023-2024 | Sapien 3 Ultra Resilia |
| Abiomed | $127.97 | 2023-2024 | Impella |
| Boston Scientific Corporation | $103.14 | 2024-2025 | Versacross Steerable Access Solution, Watchdog, Versacross Access Solution |
| Medtronic, INC. | $96.00 | 2021-2023 | Na |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $78.54 | 2022-2023 | Lifevest |
| Angiodynamics, INC. | $42.34 | 2022 | |
| Lantheus Medical Imaging, INC. | $23.72 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $17.63 | 2021 | |
| Janssen Biotech, INC. | $13.66 | 2024 | Stelara |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beverly Wood listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.